216 filings
Page 4 of 11
8-K
it4 gaqvdp7
13 Aug 19
Nephros Announces Listing on Nasdaq Capital Market
7:45am
8-K
2ri9e 7fro7qos3dlze
7 Aug 19
Nephros Reports Second Quarter Financial Results
4:15pm
8-K
4q4j n3ed
2 Aug 19
Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July
5:01pm
8-K
labs6j4uav
9 Jul 19
Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split
4:10pm
8-K
pdph8vz8pev 5t
22 May 19
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
d6zaqxqjr71r encu0
16 May 19
Nephros Announces $2 Million Private Placement
7:35am
8-K
z8eze
8 May 19
Nephros Reports First Quarter Financial Results
4:15pm
8-K
6vzm08iwrc5s
2 May 19
Nephros Appoints Tom Gwydir to its Board of Directors
10:25am
8-K
fqwyrqioptra99d7
9 Apr 19
Nephros Announces Preliminary Financial Results for First Quarter 2019
4:15pm
8-K
ijv0andy6v1y2n09as
12 Mar 19
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
7:50am
8-K
j2fxz89jbsc5us9xb
13 Feb 19
Nephros Appoints Alisa Lask to its Board of Directors
12:00am
8-K
ebpz0
9 Jan 19
Nephros Announces Preliminary Financial Results for Fiscal Year 2018
5:20pm
8-K
h65wby28
3 Jan 19
Nephros Announces Acquisition of Biocon
9:41am
8-K
56ezhsrf6mq2lz
19 Dec 18
Departure of Directors or Certain Officers
4:15pm
8-K
c0bx 241rp3yc3uxd
10 Dec 18
Other Events
5:23pm
8-K
ylqfl5alf2i3
2 Oct 18
Results of Operations and Financial Condition
4:05pm
8-K
msoz39ofh57nna0
11 Sep 18
Specialty Renal Products Announces $3 Million Series A Financing
12:00am
8-K
7jsmju5xrd9v
13 Aug 18
Nephros Appoints Oliver Spandow to its Board of Directors
4:31pm
8-K
isai872v9 2pr1
12 Jul 18
Nephros Announces Preliminary Financial Results for Second Quarter 2018
9:59am
8-K
4jwwc 7yuss0
24 May 18
Departure of Directors or Certain Officers
4:15pm